Prophylactic use of nasalferon against COVID-19 in healthcare workers. Early surveillance study
Introduction: In Cuba, the nasal application of recombinant human IFN-alpha- 2b (nasalferon) began in personnel at risk in order to prevent SARS-CoV-2 infection. Objective: To characterize the safety in those subjects exposed to the use of Nasalferon at the Surgical Medical Research Center and to e...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universidad de Ciencias Médicas de La Habana
2022-05-01
|
Series: | Revista Habanera de Ciencias Médicas |
Subjects: | |
Online Access: | http://www.revhabanera.sld.cu/index.php/rhab/article/view/4759 |